COVID-19

Americas update and vaccine development

COVID -19, Global Update, June
Cases, 9,273,773
Deaths, 477,807

US
Cases, 2,347,102
Deaths, 121,225

Seven US states have reported their highest coronavirus patient admissions

Arizona, Arkansas, California, North Carolina, South Carolina, Tennessee and Texas

Texas, record daily case increase on Tuesday

California + 5,000 cases

Cases also increasing in Arizona, Nevada and Missouri

Florida, Homestead hospital, ITU at capacity

Florida + 3,200 new cases on Tuesday

Dr Anthony Fauci (to Congress)

Wear masks in busy public spaces

Plan A, don’t go in a crowd

Plan B, if you do, make sure you wear a mask

Next few weeks would be critical

Brazil
Cases + 39,000 = 1,145,906
Deaths, 52,645
Bolsonaro ordered to wear a mask in public

Mexico
Cases + 6,288 = 191,410
Deaths + 793 = 23,377

Russia
Cases 606,043
WW2 victory parade

Experimental vaccines
About 14 being tested around the world
Successfully completed a Phase 3, none

COVID-19 vaccine tests begin in South Africa

University of Oxford’s Oxford Jenner Institute

Currently on trial in the UK, n = 4,000

Additional 10, 000 planned

South African study, rigorous review and has been approved by the South African Health

Products Regulatory Authority (SAHPRA) and the Human Research Ethics Committee of the

University of the Witwatersrand.

Trial, volunteers administered with a COVID-19 vaccine

Safety and efficacy

More than a year, provided it is found to be effective

Second half of 2021.

Engineered to express the SARS-CoV-2 spike protein

Antibodies produced against sections of the spike protein after natural infection are able to kill the virus when tested in the laboratory

Not a live vaccine, does not replicate in the body

‘It might not protect someone from becoming infected, but it will protect someone from being clinically ill’

China National Biotech Group
Approval to run a large-scale Phase 3 clinical trial in the United Arab Emirates

If you would like to donate to John’s educational project, please use the following link, thank you,